110830 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus Viruses as such, e.g. new isolates, mutants or their genomic sequences
INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT
#2Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#3INFLUENZA B VIRUS MUTANTS AND USES THEREFOR
#4INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT
#5HIGH GROWTH INFLUENZA VIRUS
#6METHOD
#7Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#8Fabric top for a convertible vehicle and convertible vehicle
#9H7 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application
#10H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor
#11Influenza B virus mutants and uses therefor
#12H5 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application
#13INFLUENZA VIRUS REASSORTMENT
#14Influenza B virus replication for vaccine development
#15Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses
#16ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#17Influenza virus reassortment
#18Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#19Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#20Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#21Influenza hemagglutinin and neuraminidase variants
#22NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#23ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#24Methods for the propagation of modified influenza viruses in embryonated eggs
#25Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#26Influenza B viruses with reduced sensitivity to neuraminidase inhibitors
#27Production of viruses, viral isolates and vaccines
#28Production of viruses viral isolates and vaccines
#29Methods and interferon deficient substrates for the propagation of viruses